Kiora Pharmaceuticals, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Kiora Pharmaceuticals, Inc. (KPRX) is 6.68

According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.68. This represents a change of -8.62% compared to the average of 7.31 of the last 4 quarters.

Kiora Pharmaceuticals, Inc. (KPRX) Historical Current Ratio (quarterly & annually)

How has KPRX Current Ratio performed in the past?

The mean historical Current Ratio of Kiora Pharmaceuticals, Inc. over the last ten years is 2.90. The current 6.68 Current Ratio has changed 22.90% with respect to the historical average. Over the past ten years (40 quarters), KPRX's Current Ratio was at its highest in in the March 2024 quarter at 21.02. The Current Ratio was at its lowest in in the December 2016 quarter at 0.57.

Kiora Pharmaceuticals, Inc. (KPRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kiora Pharmaceuticals, Inc. (KPRX) Average Current Ratio

How has KPRX Current Ratio performed in the past?

The current Current Ratio of Kiora Pharmaceuticals, Inc. (KPRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kiora Pharmaceuticals, Inc. (KPRX) Current Ratio vs. Peers

How is KPRX’s Current Ratio compared to its peers?

Kiora Pharmaceuticals, Inc.’s Current Ratio is less than Aprea Therapeutics, Inc. (8.92), greater than BioCardia, Inc. (0.41), greater than Acurx Pharmaceuticals, Inc. (3.78), less than IN8bio, Inc. (10.50), less than Creative Medical Technology Holdings, Inc. (19.69), greater than Aptevo Therapeutics Inc. (3.36), greater than HCW Biologics Inc. (0.09), less than Phio Pharmaceuticals Corp. (66.93), greater than Adial Pharmaceuticals, Inc. (3.18), greater than TransCode Therapeutics, Inc. (3.11),

Build a custom stock screener for Kiora Pharmaceuticals, Inc. (KPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kiora Pharmaceuticals, Inc. (KPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.